HHS officially extended COVID-19-era allowances for pharmacists through Dec. 31, 2024, after the agency said it planned to do so. 

This live episode from the Becker’s Hospital Review 13th Annual Meeting in Chicago features Alfred L'Altrelli, Sr Director of Pharmacy at UPMC. Here, he discusses his career journey, what he is currently most excited about in healthcare, and more. This…

As the American Medical Association pushes back on efforts to expand pharmacists' scopes of practice and lawmakers reintroduce bills aimed at increasing pharmacist roles, four leaders at hospitals and health systems weighed in on the debate. 

The American Society of Health-System Pharmacists said May 10 that quality issues at drug manufacturing sites are triggering more drug shortages. 

After five senators reintroduced a bill that looks to expand pharmacists' scope of practice and increase Medicare reimbursement for those extra services, pharmacist organizations applauded the proposed legislation. 

The FDA approved the first drug that treats agitation associated with Alzheimer's disease.

A federal judge in Illinois has tripled the amount Eli Lilly must pay after a jury found the pharmaceutical company guilty of violating the False Claims Act in August 2022, according to a May 9 report from Law360.

For five months, drugmakers have reported changing resupply dates for cisplatin, an oncology treatment in short supply. The release date just changed again, according to the American Society of Health-System Pharmacists' latest update. 

The pharmacy department at Edison, N.J.-based Hackensack Meridian Health is planning for growth as the network reports a multimillion-dollar net loss. 

A study of 20 people with obesity hinted at the possibility for semaglutide — the active ingredient in Type 2 diabetes drug Ozempic and weight-loss drug Wegovy — to increase the functionality of natural killer cells, which destroy cancerous cells.